2,156
Total Claims
$417K
Drug Cost
533
Beneficiaries
$783
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-45%
Cost per patient vs peers
$783 vs $1,411 avg
+195%
Brand preference vs peers
31.4% vs 10.6% avg
Brand vs Generic
69% generic
Brand: 676 claims · $386K
Generic: 1,480 claims · $31K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 87 | $125K |
| Dabigatran Etexilate Mesylate | 280 | $85K |
| Rivaroxaban | 31 | $36K |
| Empagliflozin | 44 | $27K |
| Sacubitril/Valsartan | 12 | $23K |
| Evolocumab | 29 | $20K |
| Ticagrelor | 12 | $17K |
| Dronedarone Hcl | 13 | $13K |
| Bisoprolol Fumarate | 233 | $6,373 |
| Furosemide | 294 | $3,591 |
| Potassium Chloride | 27 | $2,319 |
| Metoprolol Tartrate | 158 | $1,736 |
| Ranolazine | 20 | $1,587 |
| Nitroglycerin | 88 | $1,342 |
| Digoxin | 46 | $1,161 |
Prescribing Profile
32
Unique Drugs
$211K
Patient Profile
78
Avg Age
52%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About